1915 (1915) Fair Value & Analysis

Financial Services · Market cap HK$159M

1 1915 1915 · HK

PriceHK$0.2650

Fair ValueHK$0.5300

Upside+100.0%

Quality55/100

Watch 1915 for free — get notified when fair value or trend changes. Watch for free

Evidence: Low Range HK$0.3960 – HK$0.6640

Fair value as of: Jul 2, 2026

From 6 valuation models · updated today

Price vs Fair Value (12 months)

12‑month range HK$0.2650 – HK$0.2650 · fair‑value band HK$0.3960 – HK$0.6640 · the HK$0.2650 price screens below the HK$0.5300 fair value. As of Jul 2, 2026.

✦ Which stocks are undervalued right now? Check free Discover now →

Analysis

1915 (1915) currently trades at HK$0.2650, while our model-based Fair Value estimate is HK$0.5300 — implying the stock looks roughly 100.0% undervalued today. We read business quality at 55/100 (solid quality), in the Financial Services sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: low) — always confirm before acting.

Over the trailing twelve months, 1915 generated revenue of HK$52.3M at a net margin of -9.6%. Revenue grew 25.8% year over year. It earns a return on equity of -0.6%. Fundamentals as of Jul 2, 2026

Key figures & financial health

Revenue (TTM) HK$52.3M

Revenue growth (YoY) +25.8%

Net margin -9.6%

Return on equity -0.6%

Free cash flow −HK$2.5M FY2023

Operating margin 155%

More key figures

Net cash HK$279K FY2023

Figures from reported company fundamentals (EODHD) · as of Jul 2, 2026. TTM = trailing twelve months.

Revenue & earnings trend

FY2019 – FY2023 · reported fiscal years

1915 reported revenue of HK$52.4M in FY2023 versus HK$94.0M in FY2019, a compound −13.6%/yr. Reported net income was −HK$8.2M in FY2023.

Revenue −13.6%/yr

FY19 HK$94.0M

FY20 HK$76.6M

FY21 HK$62.5M

FY22 HK$53.5M

FY23 HK$52.4M

Net income

FY19 HK$50.1M

FY20 HK$36.7M

FY21 HK$4.6M

FY22 −HK$9.8M

FY23 −HK$8.2M

Is 1915 fairly valued? → Check now

Similar stocks

6 more Credit Services stocks, each showing price versus our Fair Value estimate (as of Jul 2, 2026).

Stock	Price	Fair Value	vs Fair Value
Visa Inc V	5,663 MXN	229.36 MXN	-96%
Mastercard Incorporated MA	C$29.95	C$17.76	-41%
M4I M4I	€430.50	€368.29	-14%
American Express Company AXP	C$28.87	C$24.27	-16%
Capital One Financial Corporation COF	$200.70	$125.08	-38%
Bajaj Finance Limited BAJFINANCE	₹889.40	₹559.13	-37%

Explore undervalued stocks

More undervalued Financial Services stocks →

All undervalued stocks Technology Financial Services Healthcare Consumer Cyclical Consumer Defensive Communication Services Industrials Energy Basic Materials Real Estate Utilities Deeply Undervalued Stocks Undervalued Blue-Chip Stocks Undervalued Small-Cap Stocks

Frequently asked questions

Is 1915 (1915) undervalued?

As of Jul 2, 2026, our model estimates a fair value of HK$0.5300 versus a price of HK$0.2650 — about +100% (undervalued). Model-based estimate, not financial advice.

What is the fair value of 1915?

Our model-based fair value for 1915 is HK$0.5300 (as of Jul 2, 2026), built from audited fundamentals. The current price is HK$0.2650.

What is the quality score of 1915?

1915 has a Quality Score of 55/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

What is the revenue of 1915 (1915)?

1915 reported trailing-twelve-month revenue of about HK$52.3M (latest available figure, as of Jul 2, 2026).

What is the net profit margin of 1915?

The net profit margin of 1915 is about -9.6%, meaning it is currently running at a net loss. Based on the latest reported figures.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.